Nantong JiangTian Chemical (300927)

Search documents
江天化学(300927) - 平安证券股份有限公司关于南通江天化学股份有限公司2024年度募集资金存放与使用情况的核查意见
2025-04-17 12:51
平安证券股份有限公司 关于南通江天化学股份有限公司 2024 年度募集资金存放与使用情况的核查意见 平安证券股份有限公司(以下简称平安证券或保荐机构)作为南通江天化学 股份有限公司(以下简称江天化学或公司)首次公开发行股票并在深圳证券交易 所创业板上市的保荐机构,根据《证券发行上市保荐业务管理办法》《深圳证券 交易所创业板股票上市规则》和《深圳证券交易所上市公司自律监管指引第 2 号 ——创业板上市公司规范运作》等有关规定,就江天化学 2024 年度募集资金存 放与使用相关情况进行了核查,发表意见如下: 一、募集资金基本情况 (一)实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于同意南通江天化学股份有限公司首次公开 发行股票注册的批复》(证监许可[2020]3213 号)同意注册,公司首次公开发行 人民币普通股(A 股)2,005 万股,每股面值人民币 1.00 元,发行价格为 13.39 元,募集资金总额为 268,469,500.00 元,由保荐机构扣除保荐承销费用 28,500,000.00 元(不含增值税)后的余额 239,969,500.00 元,并扣除其他发行 费 用 11,491, ...
江天化学(300927) - 2025 Q1 - 季度财报
2025-04-17 12:50
Financial Performance - The company's revenue for Q1 2025 was CNY 350,419,768.39, representing a 104.57% increase compared to CNY 171,299,011.23 in the same period last year[4] - Net profit attributable to shareholders decreased by 93.42% to CNY 818,770.12 from CNY 12,446,146.76 year-on-year[4] - The net profit after deducting non-recurring gains and losses fell by 97.64% to CNY 293,160.31 from CNY 12,396,405.64 in the previous year[4] - The total profit for the current period is 1,990,844.47, down from 16,465,959.92 in the previous period, indicating a decrease of about 87.9%[16] - The operating profit for the current period is 1,790,031.39, compared to 16,462,159.92 in the previous period, reflecting a decline of approximately 89.1%[16] - The basic and diluted earnings per share for the current period are both 0.0057, a significant drop from 0.0862 in the previous period[17] - The total comprehensive income for the current period is 818,770.12, down from 12,446,146.76 in the previous period, reflecting a decrease of about 93.4%[17] Cash Flow - The net cash flow from operating activities improved by 181.46%, reaching CNY 22,375,298.74 compared to a negative CNY 27,468,437.33 in the same period last year[4] - The cash flow from operating activities for the current period is 22,375,298.74, a significant improvement from a negative cash flow of -27,468,437.33 in the previous period[18] - The cash flow from investing activities shows a net outflow of -325,984,560.51, worsening from -128,415,133.47 in the previous period[19] - The cash flow from financing activities for the current period is 31,923,461.48, down from 110,749,830.30 in the previous period, indicating a decrease of approximately 71.1%[19] - The company received cash from sales of goods and services totaling 341,691,338.76, a significant increase from 138,994,616.50 in the previous period, representing an increase of about 146.0%[18] Assets and Liabilities - Total assets decreased by 11.02% to CNY 1,956,761,840.45 from CNY 2,199,096,987.89 at the end of the previous year[4] - Cash and cash equivalents decreased to ¥404,896,860.25 from ¥675,806,644.32, reflecting a decline of 40.0%[12] - Accounts receivable decreased to ¥132,349,646.04 from ¥145,470,217.47, a reduction of 9.0%[12] - Inventory levels decreased to ¥223,940,373.54 from ¥268,017,043.50, representing a decline of 16.4%[12] - Total liabilities decreased to ¥992,296,431.87 from ¥1,236,221,985.47, a reduction of 19.8%[14] Market and Competition - The company attributed the significant decline in net profit to intense market competition and price reductions across various products[6] - The increase in revenue was partly due to the consolidation of a new subsidiary, which contributed to the revenue growth[6] - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided data[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,815[8] - The gross profit margin for the current period is approximately 0.12%, compared to a margin of 0.42% in the previous period, indicating a decrease in profitability[15]
江天化学(300927) - 2024 Q4 - 年度财报
2025-04-17 12:50
Financial Performance - The company's operating revenue for 2024 was ¥688,379,172.65, a decrease of 2.92% compared to ¥709,117,773.22 in 2023[16]. - Net profit attributable to shareholders for 2024 reached ¥297,735,338.47, representing a significant increase of 334.35% from ¥68,546,910.88 in 2023[16]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥40,087,061.25, down 39.48% from ¥66,242,567.24 in 2023[16]. - The net cash flow from operating activities was ¥16,328,708.96, a decline of 81.27% compared to ¥87,183,491.98 in 2023[16]. - Basic earnings per share for 2024 were ¥2.0625, an increase of 334.39% from ¥0.4748 in 2023[16]. - Total assets at the end of 2024 amounted to ¥2,199,096,987.89, a 119.79% increase from ¥1,000,529,837.52 at the end of 2023[16]. - The company reported a total of ¥257,648,277.22 in non-recurring gains for 2024, compared to ¥2,304,343.64 in 2023[22]. - The weighted average return on equity for 2024 was 36.11%, up from 10.36% in 2023[16]. - The company achieved revenue of CNY 688.38 million, a decrease of 2.92% compared to the previous year, while net profit reached CNY 297.74 million, an increase of 334.35% year-on-year[42]. - The company's cash flow from operating activities was CNY 16.33 million, down 81.27% from the previous year[42]. Dividend Distribution - The company plans to distribute a cash dividend of 0.90 RMB per 10 shares to all shareholders, based on a total of 144,360,000 shares[3]. - The profit distribution plan for 2024 includes a cash dividend of 0.90 CNY per 10 shares, amounting to 12,992,400 CNY (including tax), with no stock dividends or capital reserve transfers[153]. - The cash dividend distribution plan aligns with the company's articles of association and has been approved by the board and shareholders[152]. - The company plans to distribute a cash dividend of 1.45 CNY per 10 shares, totaling 20,932,200 CNY (including tax) based on a total share capital of 144,360,000 shares for the 2023 fiscal year[151]. Risk Management - The company emphasizes the importance of risk awareness regarding macroeconomic fluctuations, raw material volatility, and major asset restructuring[3]. - The report outlines potential risks in its future development outlook, particularly in areas such as project construction and accounts receivable[3]. - The company reduced major risks from 17 in 2023 to 10, and the number of significant hazards decreased from 4 to 1[33]. - The company is implementing measures to manage accounts receivable risks, including strengthening collection mechanisms and optimizing contract review processes[104]. - Safety and environmental risks are present due to the nature of raw materials and production processes, prompting the company to enhance safety management and compliance measures[101]. Acquisitions and Investments - The company acquired 100% equity of Sanhe Yajia Fine Chemicals (Nantong) Co., Ltd., which is expected to significantly impact its "one body, two wings" development strategy[27]. - The company completed the acquisition of 100% equity in San Daya, expanding its business into superabsorbent resin, which enhances its product structure and customer diversification[44]. - The company completed the acquisition of 100% equity in SDP Global Co., Ltd. for cash, with the transaction approved on December 4, 2024[198]. - The newly acquired subsidiary, Nantong San Daye Fine Chemicals Co., Ltd., was included in the company's consolidated financial statements as of the end of the reporting period[198]. Research and Development - The company has established 6 R&D projects for 2024, with 29 dedicated and part-time employees involved, accounting for 13.81% of the total workforce[33]. - The company is focused on expanding its market presence by leveraging customer value and technological innovation[36]. - The company is actively developing new products, including high-purity chloromethane and high water-absorbent resins[37]. - The company plans to enhance R&D efforts with multiple products in development, aiming to launch new products based on customer demand in 2025, while also establishing a new R&D center in the southern region[99]. Safety and Environmental Compliance - The company has established a comprehensive safety, environmental protection, and occupational health management system, achieving certifications such as ISO9001, ISO14001, and ISO45001[158]. - The company is classified as a key pollutant discharge unit by environmental protection authorities, adhering to various environmental regulations and standards[168]. - The company's wastewater discharge standards include CODcr ≤ 500 mg/L, ammonia nitrogen ≤ 45 mg/L, and total phosphorus ≤ 8 mg/L, all of which are in compliance with national standards[169]. - The company has implemented upgrades to pollution control facilities, ensuring stable compliance with emission standards[171]. - The company has not experienced any major environmental pollution incidents during the reporting period[171]. Corporate Governance - The company has a total of 9 board members, including 3 independent directors, complying with legal and regulatory requirements[111]. - The supervisory board consists of 5 members, with 2 being employee representatives, and held 7 meetings during the reporting period[112]. - The company maintained a 99.4% response rate to investor inquiries on the interactive platform, ensuring timely communication and information transparency[115]. - The company operates independently from its controlling shareholder in terms of assets, personnel, finance, organization, and business, ensuring a complete and independent operational capability[116]. - The company has established an independent financial department with a clear financial management system, allowing for independent financial decision-making[116]. Employee Management - The company has a total of 374 employees at the end of the reporting period, with 210 in the parent company and 164 in major subsidiaries[148]. - The company has a total of 287 employees with a bachelor's degree or higher, representing approximately 76.7% of the total workforce[148]. - The company emphasizes internal training programs to enhance employee skills and overall company development potential[150]. - The company has implemented a salary policy based on base salary and performance bonuses, with adjustments made according to industry standards[149]. Financial Management - The company has a robust project management system in place, ensuring strict adherence to decision-making procedures and budget controls[158]. - The company has established a detailed management plan for the raised funds to ensure legal and compliant usage, aiming to improve financing structure and profitability[192]. - The company has committed to fulfilling its obligations regarding immediate return measures and ensuring compliance with regulatory requirements[196]. - The company has engaged Xinyong Zhonghe Accounting Firm for internal control auditing, with total audit fees amounting to 480,000 RMB, including 360,000 RMB for financial statement audit and 120,000 RMB for internal control audit[199]. Market Expansion - The company is actively expanding its market by developing new applications for triazine and exploring downstream derivatives[33]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $100 million allocated for potential mergers[132]. - Market expansion plans include entering two new regions, which are projected to increase market share by 10%[131]. Compliance and Legal Matters - The company has not faced any administrative penalties related to environmental issues during the reporting period[174]. - The company has not reported any major lawsuits or administrative penalties in the last three years[179]. - The company has committed to providing accurate and complete information regarding the transaction as per regulatory requirements[179]. - The company has ensured compliance with the disclosure requirements for the chemical industry as mandated by the Shenzhen Stock Exchange[176].
江天化学(300927) - 董事会对独董独立性评估的专项意见
2025-04-17 12:49
经核查,独立董事宋义虎、郁东、吴建新的任职经历以及签署的相关自查文 件,与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观判 断的关系,不存在影响独立董事独立性的情况,符合《上市公司独立董事管理办 法》《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市公司规范运作》 中对独立董事独立性的相关要求。 南通江天化学股份有限公司董事会 关于独立董事独立性情况评估的专项意见 南通江天化学股份有限公司(以下简称"公司")董事会根据《上市公司独 立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市 公司规范运作》等要求,就公司在任独立董事宋义虎、郁东、吴建新的独立性情 况进行评估并出具如下专项意见: 南通江天化学股份有限公司董事会 2025 年 4 月 16 日 ...
江天化学(300927) - 董事会战略与可持续发展委员会工作细则(2025年4月修订)
2025-04-17 12:49
第一章 总 则 第一条 为适应南通江天化学股份有限公司(以下简称"公司")战略发展需要,增 强公司核心竞争力,确定公司发展规划,健全投资决策程序,提高重大投资决策的效益 和决策的质量,完善公司治理结构,实现公司与环境、社会的协调发展,根据《公司法》 《证券法》《上市公司治理准则》《企业内部控制规范》《深圳证券交易所上市公司自律 监管指引第 2 号—创业板上市公司规范运作》和《公司章程》的相关规定,公司董事会 设立战略与可持续发展委员会,并制定本工作细则。 第二条 董事会战略与可持续发展委员会是董事会设立的专门工作机构,负责对公 司长期发展战略规划、重大投资决策和可持续发展战略进行可行性研究并提出建议,向 董事会报告工作并对董事会负责。 第二章 人员组成 第三条 战略与可持续发展委员会成员由五名董事组成,其中应至少包括独立董事 一名。 第四条 战略与可持续发展委员会委员由董事长、二分之一以上独立董事或者三分 之一以上董事提名,由董事会选举产生。 第五条 战略与可持续发展委员会设召集人一名,由董事长担任,负责主持委员会 工作。 第六条 战略与可持续发展委员会委员任期与董事会董事一致,委员任期届满,连 选可以连任。 ...
江天化学(300927) - 关于董事会战略委员会调整为董事会战略与可持续发展委员会并修订相关工作细则的公告
2025-04-17 12:49
证券代码:300927 证券简称:江天化学 公告编号:2025-019 南通江天化学股份有限公司 关于董事会战略委员会调整为董事会战略与可持续发展委员会 并修订相关工作细则的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 南通江天化学股份有限公司(以下简称"公司")于 2025 年 4 月 16 日召开 第四届董事会第十五次会议,审议通过了《关于董事会战略委员会调整为董事会 战略与可持续发展委员会并修订相关工作细则的议案》,现将具体情况公告如下: 为完善公司法人治理结构,提升公司环境、社会及公司治理工作,推动公司 可持续、高质量发展,根据有关法律法规及《公司章程》的有关规定,董事会同 意将"董事会战略委员会"调整为"董事会战略与可持续发展委员会",在原有 职责基础上增加可持续发展管理职责等内容,并将原《董事会战略委员会工作细 则》更名为《董事会战略与可持续发展委员会工作细则》,修改部分条款主要是 在原有职权不变的基础上增加 ESG 工作管理职权等内容。本次调整仅变更委员会 名称、对工作细则部分条款进行修订,其组织架构及成员职位、任期等保持不变。 修订后的 ...
江天化学(300927) - 2024年度独立董事述职报告(宋义虎)
2025-04-17 12:49
一、独立性说明 作为公司独立董事,任职期间,本人未在公司担任除独立董事以外的其他 职务,与公司、公司的控股股东不存在可能妨碍本人进行独立客观判断的关 系,本人也没有从公司、公司控股股东及其关联方取得额外的、未予披露的其 他利益。因此,不存在影响独立性的情况。 二、出席会议的情况 2024 年度独立董事述职报告 (宋义虎) 各位股东及股东代表: 本人作为南通江天化学股份有限公司(以下简称"公司")的独立董事,一 直严格按照《公司法》《证券法》《上市公司独立董事管理办法》《上市公司 治理准则》等法律法规,以及《公司章程》和《独立董事工作制度》等有关规 定和要求,本着客观、公正、独立的原则,勤勉尽责、独立履职,及时了解公 司的生产经营及发展情况,积极发挥独立董事作用,有效维护了公司整体利益 和全体股东的合法权益。现将 2024 年度履职情况报告如下: 南通江天化学股份有限公司 本报告期内,我积极参加公司召开的董事会、股东大会,恪尽职守,勤勉 尽责。会议召开前认真阅读公司提供的相关材料,研究决策事项,了解公司经 营和运作情况,为参与公司重要决策做好充分准备;会议上,以谨慎的态度行 使表决权,为会议做出科学决策起到了积 ...
化工股尾盘走强 江天化学20CM涨停
news flash· 2025-04-15 06:40
智通财经4月15日电,化工股尾盘集体走强,江天化学20CM涨停,中毅达4天3板,华融化学、迪尔化 工涨超10%,江苏索普、雪峰科技、华尔泰、亚星化学等跟涨。 化工股尾盘走强 江天化学20CM涨停 ...